Raymond James Financial Inc. purchased a new position in shares of InMode Ltd. (NASDAQ:INMD - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 79,751 shares of the healthcare company's stock, valued at approximately $1,332,000. Raymond James Financial Inc. owned approximately 0.09% of InMode at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quarry LP boosted its holdings in shares of InMode by 154.3% in the third quarter. Quarry LP now owns 3,781 shares of the healthcare company's stock valued at $64,000 after acquiring an additional 2,294 shares during the period. SBI Securities Co. Ltd. purchased a new stake in InMode in the 4th quarter valued at $87,000. National Bank of Canada FI boosted its stake in InMode by 6.2% during the 3rd quarter. National Bank of Canada FI now owns 9,985 shares of the healthcare company's stock worth $169,000 after purchasing an additional 579 shares during the period. DGS Capital Management LLC purchased a new position in InMode during the 3rd quarter worth $182,000. Finally, Orion Portfolio Solutions LLC acquired a new position in InMode in the third quarter valued at $194,000. 68.04% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
INMD has been the topic of a number of research reports. Needham & Company LLC reissued a "hold" rating on shares of InMode in a report on Tuesday, February 4th. Barclays lifted their target price on InMode from $26.00 to $29.00 and gave the company an "overweight" rating in a research note on Wednesday, February 5th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $22.25.
Get Our Latest Report on INMD
InMode Stock Down 2.0 %
NASDAQ INMD traded down $0.31 during trading hours on Monday, hitting $15.40. 1,822,859 shares of the stock were exchanged, compared to its average volume of 1,180,369. The company has a market cap of $1.07 billion, a price-to-earnings ratio of 6.55 and a beta of 1.96. InMode Ltd. has a 12-month low of $14.59 and a 12-month high of $19.99. The stock has a 50-day moving average of $18.29 and a 200 day moving average of $17.77.
InMode Company Profile
(
Free Report)
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
See Also
Before you consider InMode, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InMode wasn't on the list.
While InMode currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
